NovoSorb Matrix
K-Number: K221686 · 2022-09-15
ApplicantPolynovo Biomaterials Pty, Ltd.
Decision Date2022-09-15
Product CodeQSZ
DecisionSubstantially Equivalent
Device Summary
NovoSorb Matrix is a medical device manufactured by Polynovo Biomaterials Pty, Ltd.. It received FDA 510(k) clearance on 2022-09-15 under approval number K221686. The device is classified under product code QSZ. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the NovoSorb Matrix?
NovoSorb Matrix is a medical device that received FDA 510(k) clearance on 2022-09-15. It is manufactured by Polynovo Biomaterials Pty, Ltd.. The 510(k) number is K221686.
When was NovoSorb Matrix approved by the FDA?
NovoSorb Matrix received FDA 510(k) clearance on 2022-09-15, under approval number K221686.
What company makes NovoSorb Matrix?
NovoSorb Matrix is manufactured by Polynovo Biomaterials Pty, Ltd..
What is the FDA product code for NovoSorb Matrix?
The FDA product code for NovoSorb Matrix is QSZ.
Other Devices by Polynovo Biomaterials Pty, Ltd.
Related Devices (Code: QSZ)
K161067Mirragen Advanced Wound Matrix, 4x4, Mirragen Advanced Wound Matrix, 2x2, Mirragen Advanced Wound Matrix, 1x6Engineered Tissue Solutions, LLC
K172140NovoSorb BTM Wound Dressing (2cm x 2cm), NovoSorb BTM Wound Dressing (10cm x 10cm), NovoSorb BTM Wound Dressing (10cm x 20cm), NovoSorb BTM Wound Dressing (20cm x 40cm)Polynovo Biomaterials Pty, Ltd.
K170213SupraSDRM Biodegradable Matrix Wound DressingPolymedics Innovations, GmbH
K170300Restrata Wound MatrixAcera Surgical, Inc.
K173544Phoenix Wound MatrixNanofiber Solutions, Inc.
K193583Restrata®Acera Surgical, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.